Induction of NF-κB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: Suppression of NF-κB and neuroprotection by antioxidants

Journal of Neuroscience

Volumn 18, Issue 20, 1998, Pages 8236-8246

  Post, Anke ^a   Holsboer, Florian ^a   Behl, Christian ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Glutathione; Haloperidol; Melatonin; NF B; Oxidative stress; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; GLUTATHIONE; HALOPERIDOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MELATONIN; N ACETYLSEROTONIN; DOPAMINE RECEPTOR BLOCKING AGENT; DRUG DERIVATIVE; N-ACETYLSEROTONIN; NEUROPROTECTIVE AGENT; NEUROTOXIN; PEROXIDE; SEROTONIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PRIORITY JOURNAL; ANIMAL; CELL CLONE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; NERVE CELL; PHYSIOLOGY; TRANSACTIVATION;

ANIMALS; ANTIOXIDANTS; CELL SURVIVAL; CLONE CELLS; DOPAMINE ANTAGONISTS; GENE EXPRESSION REGULATION; GLUTATHIONE; HALOPERIDOL; HIPPOCAMPUS; MELATONIN; MICE; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; NF-KAPPA B; OXIDATIVE STRESS; PEROXIDES; SEROTONIN; TRANS-ACTIVATION (GENETICS); VITAMIN E;

EID: 0032531429     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-20-08236.1998     Document Type: Article

References (16)

1. Bains JS, Shaw CA (1997) Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal cell death. Brain Res Rev 25:335-358.
2. Baldessarini RJ, Cohen BM, Teicher MH (1988) Significance level of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry 45:79-91.
3. Baldwin AS (1996) The NF-κB and IκB proteins: new discoveries and insight. Annu Rev Immunol 14:649-668.
4. Barger SW, Mattson MP (1996) Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor. Mol Brain Res 40:116-126.
5. Bäuerle P, Henkel T (1994) Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:141-179.
6. Behl C, Davis JB, Lesley, Schubert D (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827.
7. Behl C, Rupprecht R, Skutella T, Holsboer F (1995) Haloperidol-induced cell death-mechanism and protection with vitamin E in vitro. NeuroReport 7:360-364.
8. Behl C, Lezoualc'h F, Widmann M, Rupprecht F, Holsboer F (1996) Oxidative stress-resistant cells are protected against haloperidol toxicity. Brain Res 717:193-195.
9. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F (1997) Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51:535-541.
10. Boussif O, Lezoualc'h F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethyleninime. Proc Natl Acad Sci USA 92:7297-7301.
11. Bowen WD, Moses EL, Tolentino PJ, Walker M (1990) Metabolites of haloperidol display preferential activity at ω receptors compared to dopamine-D2 receptors. Eur J Pharmacol 177:111-118.
12. Brennan P, O'Neill LAJ (1995) Effects of oxidants and antioxidants on nuclear factor κB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim Biophys Acta 1260:167-175.
13. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi XX, Lee WY, Ballard DW (1995) Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol Cell Biol 15:2809-2818.
14. Cadet JL, Lohr JB, Jeste DV (1986) Free radicals and tardive dyskinesia. Trends Neurosci 3:107-108.
15. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695.
16. Creese I, Burt D, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483.